SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Author notes

These authors contributed equally: Nina Le Bert, Anthony T. Tan

Affiliations

t

1. Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore

   Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, Christine Y. L. Tham, Morteza Hafezi, Adeline Chia, Melissa Hui Yen Chng, Meiyin Lin, Nicole Tan, Martin Linster, Wan Ni Chia, Lin-Fa Wang, Eng Eong Ooi, Jenny Guek-Hong Low & Antonio Bertoletti

t

2. Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, Singapore

   Meiyin Lin & Yee-Joo Tan

t

3. National Center of Infectious Diseases, Singapore, Singapore

   Mark I-Cheng Chen

t

4. Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore

   Shirin Kalimuddin & Jenny Guek-Hong Low

t

5. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

   Paul Anantharajal Tambyah

t

6. Division of Infectious Disease, University Medicine Cluster, National University Hospital, Singapore, Singapore

   Paul Anantharajal Tambyah

t

7. Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

   Yee-Joo Tan

t

8. Singapore Immunology Network, A*STAR, Singapore, Singapore

   Antonio Bertoletti

Corresponding author

Correspondence to Antonio Bertoletti.